PEAQX


CAS No. : 459836-30-7

(Synonyms: NVP-AAM077)

459836-30-7
Price and Availability of CAS No. : 459836-30-7
Size Price Stock
100 mg Get quote
250 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-12294
M.Wt: 454.21
Formula: C17H17BrN3O5P
Purity: >98 %
Solubility: 10 mM in DMSO
Introduction of 459836-30-7 :

PEAQX (NVP-AAM077) is an orally active and selective NMDA antagonist, with IC50 values of 270 nM and 29.6 μM for hNMDAR 1A/2A and hNMDAR 1A/2B, respectively. PEAQX can promote the activation of caspase-3 and induce cell apoptosis in cortical striatal slice cultures[1][2].
IC50 & Target:IC50: 270 nM, 29.6 μM (hNMDAR 1A/2A, hNMDAR 1A/2B)[1]. In Vitro:PEAQX (3 μM) can induce cell apoptosis and promote caspase-3 activation in cortical striatal slice cultures[2].
In Vivo:PEAQX (10-40 mg/kg; s.c.) can increase caspase-3 activity and enhance motor activity in the frontal cortex and striatum of rats in a dose-dependent manner[2].
PEAQX (10 mg/kg; once daily; i.p.) can block the CaMKIV-TORC1-CREB pathway signal induced by sigma-1 receptor (σ 1r) agonists in mice with cerebral ischemia and improve learning and memory impairments[3].

Your information is safe with us.